These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9616318)

  • 21. Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma.
    Ishimaru S; Itoh M; Hanada K; Tsuchida A; Iwao T; Kajiyama G
    Cancer; 1996 Jun; 77(11):2233-9. PubMed ID: 8635089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
    Moy AP; Arora K; Deshpande V
    Histopathology; 2016 Sep; 69(3):423-30. PubMed ID: 26841202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
    Hodolic M; Ambrosini V; Fanti S
    Nucl Med Commun; 2020 May; 41(5):411-415. PubMed ID: 32168264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.
    Evans JD; Cornford PA; Dodson A; Greenhalf W; Foster CS; Neoptolemos JP
    Pancreatology; 2001; 1(3):254-62. PubMed ID: 12120204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
    Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
    Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
    Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
    Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidermal growth factor receptor in human pancreatic cancer.
    Lemoine NR; Hughes CM; Barton CM; Poulsom R; Jeffery RE; Klöppel G; Hall PA; Gullick WJ
    J Pathol; 1992 Jan; 166(1):7-12. PubMed ID: 1538276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.
    Tamiolakis D; Simopoulos C; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Koutsougeras G; Alexiadis G; Menegaki M; Papadopoulos N
    Clin Exp Med; 2005 Oct; 5(3):106-11. PubMed ID: 16284732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LH-RH receptors in the human pancreas. Basis for antihormonal treatment in ductal carcinoma of the pancreas.
    Friess H; Büchler M; Kiesel L; Krüger M; Beger HG
    Int J Pancreatol; 1991 Oct; 10(2):151-9. PubMed ID: 1660910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas.
    Reubi JC; Waser B; Schaer JC; Laissue JA
    Int J Cancer; 1999 Jul; 82(2):213-8. PubMed ID: 10389755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
    Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
    Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis.
    Lee CS; Montebello J; Georgiou T; Rode J
    Int J Exp Pathol; 1994 Apr; 75(2):79-83. PubMed ID: 8199008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.
    Bournet B; Pointreau A; Souque A; Oumouhou N; Muscari F; Lepage B; Senesse P; Barthet M; Lesavre N; Hammel P; Levy P; Ruszniewski P; Cordelier P; Buscail L
    Pancreatology; 2012; 12(1):27-34. PubMed ID: 22487470
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Baum RP; Singh A; Schuchardt C; Kulkarni HR; Klette I; Wiessalla S; Osterkamp F; Reineke U; Smerling C
    J Nucl Med; 2018 May; 59(5):809-814. PubMed ID: 29025990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
    Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
    Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
    Sierzega M; Młynarski D; Tomaszewska R; Kulig J
    Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas.
    Reubi JC; Horisberger U; Essed CE; Jeekel J; Klijn JG; Lamberts SW
    Gastroenterology; 1988 Sep; 95(3):760-3. PubMed ID: 2899530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.